Navigation Links
Reminder: Volcano Corporation Schedules Conference Call, Webcast to Discuss Axsun Transaction
Date:1/5/2009

SAN DIEGO, Jan. 5 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, will conduct a conference call and webcast Tuesday, January 6, to discuss its acquisition of Axsun Technologies, Inc., that was announced on December 23, 2008.

The teleconference call and webcast will begin at 1 p.m., Eastern Standard Time (10 a.m., Pacific Standard Time), and can be accessed by calling (719) 325-4842, passcode 8476994, or via the company's website at http://www.volcanocorp.com. Please dial in or access the webcast 10-15 minutes prior to the beginning of the call. A replay of the conference call will be available through January 13, at (719) 457-0820, passcode 8476994, and via the company's website.

Volcano Corporation

Volcano Corporation (NASDAQ: VOLC) offers a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular and structural heart disease and guide optimal therapies. The company's intravascular ultrasound (IVUS) product line includes ultrasound consoles that can be integrated directly into virtually any modern cath lab. Volcano IVUS offers unique features, including both single-use phased array and rotational IVUS imaging catheters, and advanced functionality options, such as VH(R) IVUS tissue characterization and ChromaFlo(R). Volcano also provides functional measurement (FM) consoles and single-use pressure and flow guide wires and is developing a line of ultra-high resolution Optical Coherence Tomography (OCT) systems and catheters. Currently, more than 3,700
'/>"/>

SOURCE Volcano Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Physician Reminder: Importation is Illegal
2. Tax Season Reminder: Vehicle Donations Still Needed
3. Reminder: Exelixis Announces December 10 Webcast of Its Analyst and Investor Briefing in Conjunction with The American Society Of Hematology 48th Annual Meeting
4. Volcano Corporation Presentation at Piper Jaffray Conference to Be Webcast
5. Volcano Reports 40 Percent Growth in Quarterly Revenues
6. Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego
7. Volcano Presentation at Canaccord Adams Conference to be Webcast
8. Volcano Corporation Presentation at JMP Conference to be Webcast
9. Chilean volcano captured blasting ash
10. Volcano Reports 35 Percent Increase in Quarterly Revenues; IVUS Disposable Revenues Increase 46 Percent
11. Volcano Corporation Selects Xactly to Drive Strategic Sales Performance Management

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...GINIA BEACH, Va., Dec. 2 By now, m...okeless cigarettes continue to grow in popularity....lable at the PremiumEcigarette - the new single pi... - at the amazingly low price of $14.99. ,, "Th... the e-cigarette at a very low price, before makin...
(Date:12/2/2009)... , New Directors Represent Diverse Healthc...wswire-USNewswire/ -- The membership of the Nation... its Board of Directors and reappointed four curre...a wide range of healthcare stakeholders, including...nd public and community healthcare. ,, The new...
(Date:12/2/2009)...LADELPHIA, Dec. 2 Independence Blu...its contract with Lincoln Financial Group. IBC wil...approximately 10,000 Lincoln Financial Group emplo...tion. The Lincoln plan offerings will include the ...,, "I know I speak for all of us at Independenc...
(Date:12/2/2009)...lif.Researchers from the California Institute of T...il, and for the first time, the previously mysteri...ed ubiquitin are added by enzymes called ubiquitin...Ubiquitin chains tag target proteins for destructi... "We found that ubiquitin ligases build ubiquitin ...
(Date:12/2/2009)...is the official congress of the European Associati...of the European Society of Cardiology, where techn...resented. , New case reports will be presented ...highlighting the role of this new technology. , ...iques, it is likely that non-invasive imaging will...
Breaking Medicine News(10 mins):Health News:A Smokeless Holiday Season? Premium Electronic Cigarette Announces New Disposable Smokeless Cigarette Product 2Health News:National Quality Forum Members Elect Nine Directors to Board 2Health News:National Quality Forum Members Elect Nine Directors to Board 3Health News:Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group 2Health News:Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group 3Health News:Caltech scientists show how ubiquitin chains are added to cell-cycle proteins 2Health News:Caltech scientists show how ubiquitin chains are added to cell-cycle proteins 3Health News:Caltech scientists show how ubiquitin chains are added to cell-cycle proteins 4Health News:Media alert: EUROECHO 2009 2
... ATS Medical, Inc.,(Nasdaq: ATSI ), manufacturer ...roducts and services, today announced that it will...nded September 27, 2008 after the,market close on ... Time) to discuss its second quarter results,and c...
...28 Professional Healthcare,Resources, Inc., one o...healthcare agencies based in the Washington, DC me...been named to the 2008 Homecare Elite. The,selecti...ealthcare publisher., This annual review identifi...
...ialty Pharmacy programs expand URAC,s Pharmacy,Qua...28 URAC announced that four,companies have achiev...ograms under its Pharmacy Quality Management(SM) i...his scope for the pharmacy benefit management and ...
...tion in BRCA1 Mutation Carriers , One X chromoso...romosome in women who carry mutations in the BRCA1... with a later onset of breast or ovarian cancer in...X chromosome, the cells in a woman,s body inactiva...
...-lowering statins is associated with a statistical...n (PSA) levels, according to a report in the Octob... Cancer Institute . , Previous studies examined w... association between statins and PSA level. , In...
...patients in more than 1,500 physician practices ha...ealth-care experiences, with minority patients hav...dings suggest that while all doctors should be att...nt-centered. The study, which was led by a health ...
Other Medicine News:Health News:ATS Medical Announces Third Quarter 2008 Earnings Release Date and Conference Call 2Health News:Professional Healthcare Ranked Among the Top 25 Percent of Home Health Care Providers in the Country for 2008 2Health News:Professional Healthcare Ranked Among the Top 25 Percent of Home Health Care Providers in the Country for 2008 3Health News:Four Companies Are First to Achieve Accreditation Under Two New URAC Pharmacy Quality Management(SM) Programs 2Health News:Also in the Oct. 28 JNCI 2Health News:Also in the Oct. 28 JNCI 3Health News:Also in the Oct. 28 JNCI 4Health News:Also in the Oct. 28 JNCI 5Health News:Statin use associated with reduction in prostate specific antigen levels 2Health News:Racial and ethnic disparities detected in patient experiences 2
(Date:12/2/2009)... Cantel Medical Corp. (NY... quarter ended October 31, 2009 on December 9 befo... discuss the results at 11:00 AM ET. Participatin...Andrew A. Krakauer, President and CEO; Seth R. Seg...nior Vice President, CFO and Treasurer; and Roy K....
(Date:12/2/2009)...Newswire/ -- ALERT ALARM, a Michigan-based home an...xclusive availability of new crystal necklace medi...ce of jewelry, these personal emergency response d...cy medical response assistance. ,, (Photo: htt... ) ,, For elderly users, those with a medical c...
(Date:12/2/2009)... Dec. 2 Interleukin Gene...cal Center announced findings from a study perform...netics of osteoarthritis have been published this ...f Rheumatic Diseases and is available at http://a... Results from the study highlight importance of i...
Breaking Medicine Technology:Cantel Medical Corp. to Hold Conference Call to Discuss Results for its First Quarter Ended October 31, 2009 2Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 2Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 3Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 4New Analysis Examines Fraud in Both Private and Public Health Insurance Markets 50185 1New Analysis Examines Fraud in Both Private and Public Health Insurance Markets 50185 2New Analysis Examines Fraud in Both Private and Public Health Insurance Markets 50185 3HIV Patients May Have Stiffer Arteries 50183 1Many Adults With Asthma Are Skipping Flu Shots 50181 1Many Adults With Asthma Are Skipping Flu Shots 50181 2
...ORK, Nov. 5 - Top experts from the,Alzheimer,s Fou...espread,utilization of memory screenings, especial...ild and moderate dementia are not recognized,often...priate treatment and,other positive interventions.... J. Wesson Ashford,M.D., Ph.D., senior research sc...
...sented at the 13th Annual Meeting of Connective Ti...on demonstrates clinical activity and tolerabi...ith chemo-insensitive sarcom...c. (Nasdaq: KERX ) today announced that prelimina...l activity of KRX-0401 (perifosine) in patients,wi...
Other Medicine Technology:Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia 2Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia 3Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia 4Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 2Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 3Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 4Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 5Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 6
Snap-In Snap-Out®-II Alligator Grasping Forceps Insert
Snap-In Snap-Out®-II Strong Grasping Forceps Insert
Optima III 45 Noninsulated Maryland Dissector
Dolphin-Nose Dissector, dual-incision
Medicine Products: